Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

33 insider filings · Latest: May 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 15, 2026Apr 15 9:48 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
64,000$41.09$2.6M432,886(D)

View →

Apr 15, 2026Apr 15 9:47 PMElizabeth E ReedChief Legal Officer and GC
Sale
6,785$41.83$283.8K105,211(D)

View →

Apr 14, 2026Apr 15 9:47 PMElizabeth E ReedChief Legal Officer and GC
Sale
44,715$41.21$1.8M111,996(D)

View →

Apr 15, 2026Apr 15 9:46 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
1,014$42.61$43.2K116,899(D)

View →

Apr 14, 2026Apr 15 9:46 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
7,248$41.93$303.9K117,913(D)

View →

Apr 13, 2026Apr 15 9:46 PMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
65$28.85$1.9K125,161(D)

View →

Apr 15, 2026Apr 15 9:46 PMJula InrigCHIEF MEDICAL OFFICER
Sale
1,018$42.61$43.4K111,473(D)

View →

Apr 14, 2026Apr 15 9:46 PMJula InrigCHIEF MEDICAL OFFICER
Sale
7,215$41.93$302.5K112,491(D)

View →

Apr 6, 2026Apr 7 6:17 PMRoy D. BaynesDirector
Sale
10,000$33.00$330.0K37,500(D)

View →

Apr 1, 2026Apr 2 5:55 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
60,000$30.93$1.9M432,886(D)

View →

Apr 1, 2026Apr 2 5:55 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$30.00$300.0K105,211(D)

View →

Mar 16, 2026Mar 18 4:05 PMElizabeth E ReedChief Legal Officer and GC
Sale
10,000$28.09$280.9K105,211(D)

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 19, 2026May 21 5:00 PMBrinkley Ruth WilliamsDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMRon SquarerDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMSandra PooleDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMJohn A OrwinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMMeckler Jeffrey ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMLYONS GARY ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMTimothy CoughlinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMSuzanne Louise BruhnDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 5:00 PMRoy D. BaynesDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 5, 2026May 6 8:00 PMRoy D. BaynesDirector
Option Exercise
4,500$18.270(D)

View →

May 4, 2026May 6 8:00 PMMeckler Jeffrey ADirector
Option Exercise
8,000$16.330(D)

View →

May 4, 2026May 6 8:00 PMWilliam E. RoteChief Research Officer
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 6 8:00 PMWilliam E. RoteChief Research Officer
Option Exercise
4,2504,250(D)

View →

May 4, 2026May 6 8:00 PMElizabeth E ReedChief Legal Officer and GC
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 6 8:00 PMElizabeth E ReedChief Legal Officer and GC
Option Exercise
24,250$17.964,250(D)

View →

May 4, 2026May 6 8:00 PMJula InrigCHIEF MEDICAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 6 8:00 PMJula InrigCHIEF MEDICAL OFFICER
Option Exercise
24,250$22.404,250(D)

View →

May 4, 2026May 6 8:00 PMPeter HeermaCHIEF COMMERCIAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 6 8:00 PMPeter HeermaCHIEF COMMERCIAL OFFICER
Option Exercise
4,2504,250(D)

View →

May 4, 2026May 6 8:00 PMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
45,00045,000(D)

View →

Page 1 of 2

Next →